The rising popularity in GLP-1 agonists for metabolic health has led to a debate about application forms : transdermal systems versus pills . Typically, GLP-1 therapies were only available in tablet https://rafaeldyoe567043.theideasblog.com/41434823/glp-1-patches-vs-pills-what-right-for-the-patient